市場調查報告書
商品編碼
1481995
亞太地區維生素 K2 市場預測至 2030 年 - 區域分析 - 按產品、劑型、來源和應用Asia Pacific Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application |
亞太地區維生素K2市場預計將從2022年的2,005萬美元成長到2030年的1.8793億美元。
配銷通路的拓展推動亞太地區維生素 K2 市場
擴大維生素 K2 的分銷管道有助於讓更多人群更容易獲得這種必需營養素。與製造商密切合作,確保增加維生素 K2 產品的產量和供應,以滿足不斷成長的需求。透過與批發商建立關係,可以更容易地將這些物品分發給藥房、保健品店、超市和專業補充劑店的商家。此外,客戶可以透過在零售點查看產品展示和教育材料來了解維生素 K2 的價值。此外,與發展中經濟體的電子商務公司和網路平台合作,為客戶提供一種在線購買補充劑和其他含有維生素 K2 的物品的簡單方法也至關重要。
此外,鼓勵在日常膳食和飲料中添加維生素 K2 可以擴大補充劑市場,讓喜歡營養飲食的人更容易獲得它。與醫生、營養師和營養師等醫療保健專家合作也很重要,因為這些專家可以建議患者服用維生素 K2 補充劑並推薦購買該產品的商店。這增加了對維生素 K2 的需求。因此,透過醫療管道擴大分銷網路預計將為未來幾年的市場成長提供充足的機會。
亞太地區維生素 K2 市場概況
亞太地區維生素 K2 市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。市場的成長歸因於心血管疾病盛行率的增加以及成人和新生兒骨質疏鬆症骨變形病例的增加。然而,人們對維生素 K2 益處的認知有限,阻礙了市場的成長。由於老年人口增加、心血管疾病增加和創新產品供應等因素,預計亞太地區市場在預測期內將顯著成長。亞太地區其他地區包括泰國、紐西蘭、新加坡、緬甸、越南和菲律賓。上述國家為維生素 K2 市場提供了巨大的成長機會。
例如,2019年,根據新加坡長期照護體系適應人口老化的報告,該國14%的人口(即390萬人)年齡在65歲或以上。到 2030 年,由於預期壽命的延長,預計這一數字將達到 25%,這種人口變化對國家的健康和護理需求具有深遠的影響。此外,在紐西蘭,發生心房顫動的風險隨著年齡的成長而增加,65 歲以上人口中約5% 發生心房顫動,80 歲以上人口中約10% 發生心房顫動。也有所增加。例如,馬來西亞的醫療保健支出從2017年到2018年有所增加,2018年為427美元,比2017年成長12.22%。 ,反映10年年複合成長率率為6.6%。因此,這些因素預計將在預測期內(2022-2030年)促進市場成長。
亞太地區維生素 K2 市場收入及 2030 年預測(百萬美元)
亞太地區維生素 K2 市場區隔
亞太地區維生素 K2 市場按產品、劑型、來源、應用和國家/地區進行細分。
根據產品,亞太地區維生素 K2 市場分為 MK-4、MK-7 和組合藥物。 2022 年,MK-7 細分市場佔據亞太地區維生素 K2 市場的最大佔有率。
根據劑型,亞太地區維生素 K2 市場分為膠囊和片劑、粉末和油。 2022 年,粉末細分市場佔據亞太地區維生素 K2 市場的最大佔有率。
根據來源,亞太地區維生素 K2 市場分為天然維生素 K2 和合成維生素 K2。 2022 年,天然產品在亞太地區維生素 K2 市場中佔據更大佔有率。
根據應用,亞太地區維生素 K2 市場分為藥品、營養保健品和食品等。 2022 年,藥品領域佔據亞太地區維生素 K2 市場的最大佔有率。
按國家/地區分類,亞太地區維生素 K2 市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022 年,亞太地區其他地區將主導亞太地區維生素 K2 市場。
Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG、Novozymes AS 和 Seebio Biotech(上海)有限公司是亞太地區的一些領先公司維生素K2市場。
The Asia Pacific vitamin K2 market is expected to grow from US$ 20.05 million in 2022 to US$ 187.93 million by 2030. It is estimated to grow at a CAGR of 32.3% from 2022 to 2030.
Expansion of Distribution Channel Fuels Asia Pacific Vitamin K2 Market
Expanding the distribution channels for vitamin K2 can help improve the accessibility of this essential nutrient to a broader population. Working closely with manufacturers ensures increased production and supply of vitamin K2 products to meet the growing demand. The distribution of these items to merchants in pharmacies, health shops, supermarkets, and specialty supplement stores, can be made easier by forming relationships with wholesalers. Additionally, customers can be made aware of the value of vitamin K2 by viewing product displays and educational materials at retail locations. Also, it is critical to work with developing economies-based e-commerce companies and web-based platforms to provide customers with a simple way to buy supplements and other items containing vitamin K2 online.
Furthermore, encouraging the inclusion of vitamin K2 in everyday meals and drinks can broaden the market for supplements, making it more available to people preferring a nutritional diet. Working with healthcare experts such as doctors, nutritionists, and dietitians is also essential, as these experts can advise patients to take vitamin K2 supplements and recommend a store to buy the product. This is raising the demand for vitamin K2. Thus, the expansion of the distribution networks through medical channels is expected to provide ample opportunities for market growth in the coming years.
Asia Pacific Vitamin K2 Market Overview
The Asia Pacific Vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market in Asia Pacific is expected to witness significant growth during the forecast period due to factors such as rising elderly population, growing cardiovascular diseases, and innovative product availability. The Rest of Asia Pacific includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and the Philippines. The countries mentioned above offer significant growth opportunities for the vitamin K2 market.
For instance, in 2019, according to Singapore's long-term care system adapting to population aging report, 14% of the country's population (i.e., 3.9 million people) was aged 65 years or older. By 2030, it is expected to reach 25% due to rising life expectancy, and this demographic shift has profound implications for the country's health and care needs. Additionally, in New Zealand, the risk of developing AF increases with age and occurs in about 5% of the population over 65 years and about 10% of people older than 80. Moreover, healthcare expenditure has been observed to increase in these countries. For instance, Malaysia's healthcare spending increased from 2017 to 2018, accounting for US$ 427 in 2018, a 12.22% increase from 2017. Thailand's healthcare expenditure amounts to US$ 25.3 billion, and costs are expected to increase by US$ 47.9 billion by 2026, reflecting a 10-year compound annual growth rate of 6.6%. Therefore, such factors are expected to enhance the market growth during the forecast period (2022-2030).
Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Vitamin K2 Market Segmentation
The Asia Pacific vitamin K2 market is segmented into product, dosage forms, source, application, and country.
Based on product, the Asia Pacific vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on dosage forms, the Asia Pacific vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on source, the Asia Pacific vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Asia Pacific vitamin K2 market in 2022.
Based on application, the Asia Pacific vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Asia Pacific vitamin K2 market in 2022.
Based on country, the Asia Pacific vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific vitamin K2 market in 2022.
Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, Novozymes AS, and Seebio Biotech (Shanghai) Co Ltd are some of the leading companies operating in the Asia Pacific vitamin K2 market.